Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting
release_7fwzwudbrnh75jqfjcsgwze4cq
by
Katherine Bond, Suellen Nicholson, Seok Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnston, Tuyet Hoang, Cheryll Sia, Damian Purcell, Sharon Lewin, Mike Catton, Benjamon P Howden (+1 others)
References
NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.| Showing 1 - 22 of 22 references (in 170ms) | ||
|---|---|---|
[2020.05.31.20118273v1.1]via crossref |
A new coronavirus associated with human respiratory disease in China
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao (+ more) 2020 Nature doi:10.1038/s41586-020-2008-3 pmcid:PMC7094943 pmid:32015508 |
web.archive.org [PDF]
|
[b1]via grobid |
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;
| |
[2020.05.31.20118273v1.3]via crossref |
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
Yong-Zhen Zhang, Edward C Holmes 2020 Cell doi:10.1016/j.cell.2020.03.035 pmcid:PMC7194821 pmid:32220310 |
web.archive.org [PDF]
|
[b3]via grobid |
Cell. 2020; 181(2):223-227.
| |
[2020.05.31.20118273v1.5]via crossref |
The Promise and Peril of Antibody Testing for COVID-19
Jennifer Abbasi 2020 Journal of the American Medical Association (JAMA) doi:10.1001/jama.2020.6170 pmid:32301958 |
web.archive.org [PDF]
|
[2020.05.31.20118273v1.6]via crossref |
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M Corman, Olfert Landt, Marco Kaiser, Richard Molenkamp, Adam Meijer, Daniel KW Chu, Tobias Bleicker, Sebastian Brünink (+ more) 2020 Eurosurveillance doi:10.2807/1560-7917.es.2020.25.3.2000045 pmcid:PMC6988269 pmid:31992387 |
web.archive.org [PDF]
|
[b6]via grobid |
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3).
| |
[2020.05.31.20118273v1.8]via crossref |
Developing antibody tests for SARS-CoV-2
Anna Petherick 2020 The Lancet doi:10.1016/s0140-6736(20)30788-1 pmid:32247384 |
web.archive.org [PDF]
|
[b8]via grobid |
Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020 Apr 4;395(10230):1101-1102.
| |
[2020.05.31.20118273v1.10]via crossref |
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
[post]
Angkana T. Huang, Bernardo Garcia-Carreras, Matt D.T. Hitchings, Bingyi Yang, Leah Katzelnick, Susan M Rattigan, Brooke Borgert, Carlos Moreno (+ more) 2020 doi:10.1101/2020.04.14.20065771 pmcid:PMC7217088 pmid:32511434 |
web.archive.org [PDF]
|
[b10]via grobid |
Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick L, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. medRxiv. 2020:2020.04.14.20065771.
| |
[b11]via grobid |
Royal College of Pathologists Australasia (RCPA). Position Statement: COVID19 IgG/IgM
| |
[2020.05.31.20118273v1.13]via crossref |
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients
Nisreen M A Okba, Marcel A Müller, Wentao Li, Chunyan Wang, Corine H GeurtsvanKessel, Victor M Corman, Mart M Lamers, Reina S Sikkema (+ more) 2020 Emerging Infectious Diseases doi:10.3201/eid2607.200841 pmcid:PMC7323511 pmid:32267220 |
web.archive.org [PDF]
|
[2020.05.31.20118273v1.14]via crossref |
Evaluation of nine commercial SARS-CoV-2 immunoassays
[post]
Ria Lassaunière, Anders Frische, Zitta B Harboe, Alex CY Nielsen, Anders Fomsgaard, Karen A Krogfelt, Charlotte S Jørgensen 2020 unpublished doi:10.1101/2020.04.09.20056325 |
web.archive.org [PDF]
|
[2020.05.31.20118273v1.15]via crossref |
Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications
Fan Wu, Aojie Wang, Mei Liu, Qimin Wang, Jun Chen, Shuai Xia, Yun Ling, Yuling Zhang (+ more) 2020 Social Science Research Network doi:10.2139/ssrn.3566211 | |
[b15]via grobid |
Lassaunière R, Frische A, Harboe ZB, Nielsen AC, Fomsgaard A, Krogfelt KA, et al.
| |
[2020.05.31.20118273v1.17]via crossref |
Implications of test characteristics and population seroprevalence on 'immune passport' strategies
Daniel B Larremore, Kate M Bubar, Yonatan H Grad 2020 Clinical Infectious Diseases doi:10.1093/cid/ciaa1019 pmid:32687149 |
web.archive.org [PDF]
|
[2020.05.31.20118273v1.18]via crossref |
Laboratory Diagnosis of HIV in Adults: A Review of Current Methods
J. K. Cornett, T. J. Kirn 2013 Clinical Infectious Diseases doi:10.1093/cid/cit281 pmid:23667267 |
web.archive.org [PDF]
|
[b19]via grobid |
Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. 2020:2020.03.30.20047365.
| |
[b20]via grobid |
Australian Government Department of Health. Coronavirus (COVID-19) Current situation and case numbers. 2020. Available from: https://www.health.gov.au/news/health-alerts/novel- coronavirus-2019-ncov-health-alert/coronavirus-covid-19-current-situation-and-case-numbers, last accessed 6 th May, 2020.
| |
[b21]via grobid |
Larremore DB, Kate M. Bubar, and Yonatan H. Grad. Implications of test characteristics and population seroprevalence on 'immune passport' strategies. May 2020. Available at https://dash.harvard.edu/handle/1/42664007?show=full, last accessed 15 th May, 2020
| |
[b22]via grobid |
Cornett JK, Kirn TJ. Laboratory diagnosis of HIV in adults: a review of current methods. Clin Infect Dis 2013;57(5):712-8.
| |